Skip to content

A Study on the Median Effective Dose of Ciprofol for Induction of General Anesthesia in Obese Pediatric Patients

A Study on the Median Effective Dose of Ciprofol for Induction of General Anesthesia in Obese Pediatric Patients

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600118172
Enrollment
Unknown
Registered
2026-02-03
Start date
2026-03-01
Completion date
Unknown
Last updated
2026-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Children aged 2–6 years who require general anesthesia for surgery

Interventions

Non-obese group:The ciprofol dose for each patient was determined using the modified Dixon up-and-down sequential method. The starting dose for the first patient was 0.6 mg/kg, based on the literature
the ciprofol induction dose for the subsequent patient was increased by 0.05 mg/kg.
Obese group:The ciprofol dose for each patient was determined using the modified Dixon up-and-down sequential method. The starting dose for the first patient was 0.6 mg/kg, based on the literature, wi

Sponsors

The First People's Hospital of Yancheng
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 6 Years

Inclusion criteria

Inclusion criteria: 1. Age 2–6 years; 2. BMI between the 5th and 85th percentiles for age- and sex-matched children (non-obese group), or =95th percentile for age- and sex-matched children (obese group); 3.Children with ASA physical status I–II who require general anesthesia.

Exclusion criteria

Exclusion criteria: 1. Known hypersensitivity to ciprofol or other anesthetic agents; 2. Upper respiratory tract infection, uncontrolled asthma, or suspected difficult airway; 3. Hepatic and/or renal dysfunction; 4. Current use of antiepileptic drugs, sedatives, etc; 5. Neurodevelopmental delay.

Design outcomes

Primary

MeasureTime frame
The median effective dose (ED50) of ciprofol for successful induction in the two groups;

Secondary

MeasureTime frame
Incidence of respiratory depression;Incidence of laryngospasm;Incidence of hypotension;Incidence of bradycardia;Incidence of postoperative nausea and vomiting;Length of stay in the PACU (Post-Anesthesia Care Unit);

Countries

China

Contacts

Public ContactLiu Xiang

The First People's Hospital of Yancheng

liuxiang8591@163.com+86 136 1516 1345

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026